by PanGenomic | Mar 30, 2023 | Business Update
Vancouver, British Columbia, Canada, March 30, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. (“MUJN Diagnostics”), has signed a master services agreement with Hemex Health...
by PanGenomic | Mar 28, 2023 | Business Update
VANCOUVER, BC, March 28, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce the filing of its business acquisition report (the “BAR”) relating to its acquisition of...
by PanGenomic | Mar 22, 2023 | Business Update
VANCOUVER, BC, March 8, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its new Women’s DNA Report is now available and that it has expanded into new...
by PanGenomic | Mar 9, 2023 | Business Update
VANCOUVER, BC, March 8, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to announce that its new Women’s DNA Report is now available and that it has expanded into new...
by PanGenomic | Mar 2, 2023 | Business Update
VANCOUVER, BC, March 2, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA), is pleased to provide a corporate update on its strategic initiatives. Acquisition of Mindleap Health Inc....